Current surgical treatment policy in invasive bronchopulmonary aspergillosis
- Authors: Ter-Ovanesov M.D.1, Zakharov O.D.1, Polotsky B.Y.1, Volkova M.A.1, Tyurin I.Y.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
- Issue: No 1-2 (2006)
- Pages: 108-112
- Section: COMPLICATIONS AND THEIR THERAPY
- Published: 23.05.2006
- URL: https://oncohematology.abvpress.ru/ongm/article/view/655
- DOI: https://doi.org/10.17650/1818-8346-2006-0-1-2-108-112
- ID: 655
Cite item
Full Text
Abstract
Invasive aspergillosis is one of the most life-threatening complications of treatment of oncohematological diseases. In the literature there is no consensus of treatment options and indications for surgical treatment. The authors have observed 2 cases of invasive aspergillosis in patients with acute myeloid leukemia. Both patients needed pneumonectomy but the first of them received only conservative therapy because of bad general condition and died of pulmonary hemorrhage. In the second case primary lobectomy and postoperative reatment with caspofungin led to recovery and permitted to continue chemotherapy. Now this patient is in complete remission of acute myeloid leukemia.
About the authors
M. D. Ter-Ovanesov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Author for correspondence.
Moscow
Russian FederationO. D. Zakharov
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Moscow
Russian FederationB. Ye. Polotsky
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Moscow
Russian FederationM. A. Volkova
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Moscow
Russian FederationI. Ye. Tyurin
N.N. Blokhin Russian Cancer Research Cancer, Russian Academy of Medical Sciences
Moscow
Russian FederationReferences
Supplementary files

